← FDA Drug Approvals (Drugs@FDA)

ZEPBOUND

NDA · New Drug Application · Sponsor: ELI LILLY AND CO · Approved 2023-11-08

Drug application

FDA Application #

NDA217806

Application type

New Drug Application

Brand name

ZEPBOUND

Generic name

TIRZEPATIDE

Active ingredients

TIRZEPATIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ELI LILLY AND CO

Manufacturer

Eli Lilly and Company

First approval

2023-11-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown